Insight Pharmaceuticals Corp — Form D
Insight Pharmaceuticals Corp of LANGHORNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-14. The offering totals $5.6M, of which $5.6M was reported sold. Industry: Other.
Offering
- Filed: 2011-03-14
- Form: D
- Accession: 0001467468-11-000004
- Industry: Other
- Exemptions: 06
- Total offering: $5.6M
- Amount sold: $5.6M
- Investors: 6
- Date of first sale: 2011-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-156655
Issuer
- Name: Insight Pharmaceuticals Corp
- CIK: 0001467468
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1170 WHEELER WAY, SUITE 150, LANGHORNE, PA, 19047
- Phone: 800-344-7239
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Kipp C DeVeer | Director | Langhorne, PA |
| Michael C Smith | Director | Langhorne, PA |
| Michael C Westhusing | Director | Langhorne, PA |
| Mickael Tukdarian | Executive Officer | Langhorne, PA |
| Robert Monk | Director | Reston, VA |
| Kipp deVeer | Director | New York, NY |
| C. MORRIS STOUT | Director | SAN FRANCISCO, CA |
| C. MORRIS STOUT | Executive Officer | SAN FRANCISCO, CA |
| DANIEL C REESE | Director | SAN FRANCISCO, CA |
| DANIEL C REESE | Executive Officer | SAN FRANCISCO, CA |
| Scott C Emerson | Director | Trevose, PA |
| MARK POFF | Director | SAN FRANCISCO, CA |
| MARK POFF | Executive Officer | SAN FRANCISCO, CA |
| Mark C Poff | Director | San Francisco, CA |
| Mark C Poff | Executive Officer | San Francisco, CA |
| Gary Downing | Director | Langhorne, PA |
| Gary Downing | Executive Officer | Langhorne, PA |
| Dennis Kinsey | Executive Officer | Langhorne, PA |
| James Berwick | Executive Officer | Langhorne, PA |
| Mickael Tukdarian | Director | Langhorne, PA |
| Craig Hille | Director | Washington, DC |
| Joseph Suprenuk | Executive Officer | Langhorne, PA |
Other filings by this issuer (2)
More